Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.83 - $1.12 $35,901 - $48,445
-43,255 Reduced 53.32%
37,864 $33,000
Q4 2022

Feb 13, 2023

BUY
$1.09 - $2.04 $1,291 - $2,417
1,185 Added 1.48%
81,119 $102,000
Q2 2022

Aug 15, 2022

BUY
$1.39 - $3.12 $111,108 - $249,394
79,934 New
79,934 $157,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.